Chemoinformaics analysis of C QUINIDINE-POLYGALACTURONATE
| Molecular Weight | 518.563 | nRot | 9 |
| Heavy Atom Molecular Weight | 484.291 | nRig | 21 |
| Exact Molecular Weight | 518.226 | nRing | 5 |
| Solubility: LogS | -2.751 | nHRing | 4 |
| Solubility: LogP | 2.719 | No. of Aliphatic Rings | 3 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 1 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 11 |
| nHA | 10 | APOL | 75.509 |
| nHD | 6 | BPOL | 40.431 |
| QED | 0.878 |
| Synth | 4.516 |
| Natural Product Likeliness | 0.831 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.965 |
| Pgp-sub | 0.164 |
| HIA | 0.027 |
| CACO-2 | -4.61 |
| MDCK | 0.0000162 |
| BBB | 0.868 |
| PPB | 0.812537 |
| VDSS | 2.704 |
| FU | 0.184919 |
| CYP1A2-inh | 0.103 |
| CYP1A2-sub | 0.953 |
| CYP2c19-inh | 0.182 |
| CYP2c19-sub | 0.935 |
| CYP2c9-inh | 0.042 |
| CYP2c9-sub | 0.364 |
| CYP2d6-inh | 0.97 |
| CYP2d6-sub | 0.942 |
| CYP3a4-inh | 0.28 |
| CYP3a4-sub | 0.742 |
| CL | 3.316 |
| T12 | 0.22 |
| hERG | 0.683 |
| Ames | 0.158 |
| ROA | 0.323 |
| SkinSen | 0.052 |
| Carcinogencity | 0.226 |
| EI | 0.012 |
| Respiratory | 0.941 |
| NR-Aromatase | 0.014 |
| Antiviral | Yes |
| Prediction | 0.849299 |